ELEVATE – evaluating Temozolomide and Nivolumab in patients with advanced unresectable previously treated oesophagogastric adenocarcinoma with MGMT methylation: study protocol for a single arm phase II trial

Peer Review reports

Original Submission
15 Feb 2022	Submitted	Original manuscript
21 Apr 2022	Reviewed	Reviewer Report
22 Apr 2022	Reviewed	Reviewer Report
17 May 2022	Author responded	Author comments - Elizabeth Smyth
Resubmission - Version 2
17 May 2022	Submitted	Manuscript version 2
19 May 2022	Reviewed	Reviewer Report
28 May 2022	Reviewed	Reviewer Report
8 Jul 2022	Author responded	Author comments - Elizabeth Smyth
Resubmission - Version 3
8 Jul 2022	Submitted	Manuscript version 3
Publishing
13 Jul 2022	Editorially accepted
1 Sep 2022	Article published	10.1186/s12885-022-09891-9

Back to article page